On this week’s episode, as April 2 is World Autism Day, we have a conversation with Manish Arora, CEO of LinusBio, on its test that can rule out if someone has autism, and we talk to Thomas Kledal, CEO of Synklino, about improving kidney transplantation outcomes through better cytomegalovirus (CMV) prevention.

Times:

03:18 LinusBio

35:43 Synklino

LinusBio

LinusBio has expanded access to its ClearStrand ASD test, the first non-invasive biochemical tool to rule out autism spectrum disorder (ASD), for children up to age 10. The limit was previously four years of age).

Using only a strand of hair, the CLIA-certified test offers 90% sensitivity to aid early diagnosis. It is available by ...